Oct 10, 2018
Laser Interstitial Thermal Therapy (LITT) is one of a hopeful treatment for brain cancer. Now, researchers are also using lasers to activate cancer-destroying drugs and other groups are testing the use of electrical fields to intersect the cancer cells division. The researchers are yet to determine the effectiveness...
Read More...
Oct 09, 2018
FDA approves transthyretin amyloidosis therapy of Akcea, Ionis Patients with an orphan, hereditary disease that is transthyretin amyloidosis with a second new treatment option are available after the Food and Drug Administration approved Akcea Therapeutics and Ionis Pharmaceuticals' Tegsedi. As Tegsedi is approved,...
Read More...
Sep 04, 2024
As breast cancer continues to be a significant health concern for women worldwide, it is crucial to understand the importance of precautions for breast cancer. By being proactive and taking preventive measures, women can reduce their risk of developing this disease and improve their overall health. In this comprehe...
Read More...
Oct 04, 2018
Hologic complements Focal Therapeutics to its breast-conserving surgery for USD 125 Million Hologic, a global champion of women's health based in Massachusetts, United States, is taking possession of Focal Therapeutics, a medical device company, for USD 125 million to complement its breast-conserving surgery permit...
Read More...
Oct 03, 2018
Millions of people get bad side-effects when trying to withdraw antidepressants. The All Party Parliamentary Group for Prescribed Drug Dependence review shows half of the patients have withdrawal symptoms and for half of these, the symptoms will be severe. The patients should be properly warned for the same.The revi...
Read More...
Sep 28, 2018
Companion diagnostics domain falls within the larger field of study called pharmacogenomics, which employs the person’s genomic makeup to predict a drug response or to tailor therapy specifically for that patient. The US FDA depicts companion diagnostics as an in vitro diagnostic device or an imaging tool, which pro...
Read More...
Sep 27, 2018
Ceribell raises USD 35 Million in series B round Ceribell, Emergency EEG maker raised USD 35 million for commercializing its EEG system that can rapidly diagnose patients, who are supposed of not having convulsive seizures with no visual symptoms for the use in neurological intensive care units and emergency rooms. ...
Read More...
Sep 26, 2018
Functional β-cell mass loss leads to the pathogenesis of type 1 diabetes mellitus (T1DM) and also adds to type 2 diabetes mellitus (T2DM). Genetically induced downregulation of Arx, a key transcription factor for glucagon-producing α-cell specification and phenotype, in α-cells converts them into insulin-producing β...
Read More...